Sangamo Biosciences's total assets for Q2 2025 were $97.56M, an increase of 13.22% from the previous quarter. SGMO total liabilities were $77.96M for the fiscal quarter, a -4.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.